| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BECTON DICKINSON & CO | Director | Common Stock | 23,143 | $4,450,398 | $192.30 | 08 Aug 2025 | Direct |
| Seres Therapeutics, Inc. | Director | Stock Option (right to buy) | 6,452 | 01 Jul 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BDX | BECTON DICKINSON & CO | 10 Sep 2025 | 1 | -$171,938 | 4 | Director | 11 Sep 2025, 12:36 |
| BDX | BECTON DICKINSON & CO | 08 Aug 2025 | 1 | -$165,955 | 4 | Director | 08 Aug 2025, 18:56 |
| MCRB | Seres Therapeutics, Inc. | 01 Jul 2025 | 1 | $0 | 4 | Director | 02 Jul 2025, 17:34 |
| MCRB | Seres Therapeutics, Inc. | 10 Apr 2025 | 1 | $0 | 4 | Director | 11 Apr 2025, 16:05 |
| BDX | BECTON DICKINSON & CO | 28 Jan 2025 | 1 | $0 | 4 | Director | 30 Jan 2025, 16:01 |
| MCRB | Seres Therapeutics, Inc. | 04 Apr 2024 | 1 | $0 | 4 | Director | 08 Apr 2024, 16:45 |
| BDX | BECTON DICKINSON & CO | 23 Jan 2024 | 1 | $0 | 4 | Director | 25 Jan 2024, 16:15 |
| BDX | BECTON DICKINSON & CO | 28 Aug 2023 | 1 | -$238,848 | 4 | Director | 30 Aug 2023, 09:48 |
| MCRB | Seres Therapeutics, Inc. | 22 Jun 2023 | 1 | $0 | 4 | Director | 23 Jun 2023, 17:25 |
| BDX | BECTON DICKINSON & CO | 24 Jan 2023 | 1 | $0 | 4 | Director | 26 Jan 2023, 17:05 |
| MCRB | Seres Therapeutics, Inc. | 04 Jan 2023 | 1 | $0 | 4 | Director | 05 Jan 2023, 15:35 |
| MCRB | Seres Therapeutics, Inc. | 04 Jan 2023 | 0 | $0 | 3 | Director | 05 Jan 2023, 15:30 |
| BDX | BECTON DICKINSON & CO | 08 Feb 2022 | 1 | -$228,500 | 4 | Director | 10 Feb 2022, 09:17 |
| BDX | BECTON DICKINSON & CO | 25 Jan 2022 | 1 | $0 | 4 | Director | 27 Jan 2022, 07:23 |
| BDX | BECTON DICKINSON & CO | 18 Aug 2021 | 1 | -$97,361 | 4 | Director | 18 Aug 2021, 12:29 |
| BDX | BECTON DICKINSON & CO | 27 May 2021 | 1 | -$94,130 | 4 | Director | 28 May 2021, 09:57 |